Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Gillespie

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
BMC Cancer|September 16, 2018
Validation of a frailty index in older cancer patients with solid tumoursA L McCarthy, N M Peel, K M Gillespie, et al.
Cellular and Molecular Life Sciences : CMLS|April 20, 2002
The interleukin-10-1082 G/A polymorphism: allele frequency in different populations and functional significanceL E N Rees, N A P Wood, K M Gillespie, et al.
Diabetologia|May 28, 2008
Autoantibodies to islet antigen-2 are associated with HLA-DRB1*07 and DRB1*09 haplotypes as well as DRB1*04 at onset of type 1 diabetes: the possible role of HLA-DQA in autoimmunity to IA-2A J K Williams, R J Aitken, M A-M Chandler, et al.
Diabetologia|September 19, 2003
The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescenceA J K Williams, A J Norcross, R J Dix, et al.
Diabetes Care|December 10, 1999
Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?S G Gardner, E A Gale, A J Williams, et al.
Tissue Antigens|February 13, 2001
HLA class II typing of whole genome amplified mouth swab DNAK M Gillespie, S J Valovin, J Saunby, et al.
Clinical and Experimental Immunology|July 11, 2000
Exogenous type-1 cytokines modulate mercury-induced hyper-IgE in the ratM J Gorrie, F J Qasim, C J Whittle, et al.
Clinical and Experimental Immunology|October 1, 2022
The longitudinal loss of islet autoantibody responses from diagnosis of type 1 diabetes occurs progressively over follow-up and is determined by low autoantibody titres, early-onset, and genetic variantsC L Williams, R Fareed, G L M Mortimer, et al.
Clinical and Experimental Immunology|February 13, 2018
A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family studyA Kozhakhmetova, R C Wyatt, C Caygill, et al.
Human Molecular Genetics|March 1, 1993
The isolation of cDNAs within the Huntington disease region by hybridisation of yeast artificial chromosomes to a cDNA libraryR G Snell, L A Doucette-Stamm, K M Gillespie, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
BMC Cancer|September 16, 2018
Validation of a frailty index in older cancer patients with solid tumoursA L McCarthy, N M Peel, K M Gillespie, et al.
Cellular and Molecular Life Sciences : CMLS|April 20, 2002
The interleukin-10-1082 G/A polymorphism: allele frequency in different populations and functional significanceL E N Rees, N A P Wood, K M Gillespie, et al.
Diabetologia|May 28, 2008
Autoantibodies to islet antigen-2 are associated with HLA-DRB1*07 and DRB1*09 haplotypes as well as DRB1*04 at onset of type 1 diabetes: the possible role of HLA-DQA in autoimmunity to IA-2A J K Williams, R J Aitken, M A-M Chandler, et al.
Diabetologia|September 19, 2003
The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescenceA J K Williams, A J Norcross, R J Dix, et al.
Diabetes Care|December 10, 1999
Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?S G Gardner, E A Gale, A J Williams, et al.
Tissue Antigens|February 13, 2001
HLA class II typing of whole genome amplified mouth swab DNAK M Gillespie, S J Valovin, J Saunby, et al.
Clinical and Experimental Immunology|July 11, 2000
Exogenous type-1 cytokines modulate mercury-induced hyper-IgE in the ratM J Gorrie, F J Qasim, C J Whittle, et al.
Clinical and Experimental Immunology|October 1, 2022
The longitudinal loss of islet autoantibody responses from diagnosis of type 1 diabetes occurs progressively over follow-up and is determined by low autoantibody titres, early-onset, and genetic variantsC L Williams, R Fareed, G L M Mortimer, et al.
Clinical and Experimental Immunology|February 13, 2018
A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family studyA Kozhakhmetova, R C Wyatt, C Caygill, et al.
Human Molecular Genetics|March 1, 1993
The isolation of cDNAs within the Huntington disease region by hybridisation of yeast artificial chromosomes to a cDNA libraryR G Snell, L A Doucette-Stamm, K M Gillespie, et al.
Pageof 4